Vanguard Personalized Indexing Management
HAE icon

Vanguard Personalized Indexing Management’s Haemonetics HAE Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Buy
5,534
+1,203
+28% +$77.3K ﹤0.01% 1512
2026
Q1 		$244K Buy
4,331
+325
+8% +$21.2K ﹤0.01% 1721
2025
Q4 		$321K Buy
+4,006
New +$269K ﹤0.01% 1479
2025
Q3 		– Sell
-4,504
Closed -$336K – 2017
2025
Q2 		$336K Buy
+4,504
New +$298K ﹤0.01% 1390
2025
Q1 		– Sell
-3,803
Closed -$297K – 1875
2024
Q4 		$297K Buy
+3,803
New +$305K ﹤0.01% 1340
2024
Q3 		– Sell
-3,756
Closed -$294K – 1794
2024
Q2 		$294K Buy
3,756
+1,112
+42% +$97.8K 0.01% 1282
2024
Q1 		$226K Sell
2,644
-1,918
-42% -$151K ﹤0.01% 1399
2023
Q4 		$390K Buy
+4,562
New +$394K 0.01% 1123

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's HAE Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Haemonetics (HAE) stake by 28% in Q2 2026, buying an estimated $77.3K and bringing the position to 5,534 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Vanguard Personalized Indexing Management first reported a position in HAE in Q4 2023 and has held it in 8 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Vanguard Personalized Indexing Management held 5,534 shares of Haemonetics worth $415K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 1,203 Haemonetics shares in Q2 2026, an estimated $77.3K.
  • Haemonetics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1512 holding.
  • Vanguard Personalized Indexing Management first reported a position in Haemonetics in Q4 2023 and has held it in 8 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.